Company patents
ACUCELA INC.
ACUCELA INC. exhibits a surprising patent strategy, with a significant portion of its portfolio (37.5%) in Medical Diagnostics & Surgery, yet showing a -30.0% decline in 2024 and no growth in 2025, suggesting a shifting priority from its core medical device focus. Concurrently, the company appears to be rapidly divesting from various pharma-biotech and computing categories, with Heterocyclic Compounds (Pharma), Pharmaceutical Preparations, Acyclic / Carbocyclic Compounds, Image Processing, Machine Learning & AI, Computer Vision, and Healthcare Informatics all experiencing a -100.0% decline in 2025 after a surge in 2024.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
64 US filings (since 2023) · 12 categories · 9 themes
Development of sophisticated optical lens assemblies and computational methods to achieve high-resolution, precise, or specialized imaging, often for medical or scientific applications.
Techniques and systems for measuring three-dimensional shapes, depths, or surface profiles using optical principles, including diffraction, interferometry, structured light, and imaging.
Optical systems and components specifically designed for head-mounted displays, augmented reality (AR) glasses, and virtual reality (VR) headsets, focusing on image projection, waveguide integration, and display durability.
Systems and methods that use imaging technologies, computer vision, and augmented reality to provide real-time guidance, localization, and visualization during surgical procedures or for detailed anatomical assessment.
Design and synthesis of acyclic or carbocyclic organic compounds that selectively modulate specific biological targets or pathways for the treatment of diseases.
Development of small molecules, often bifunctional (e.g., PROTACs) or molecular glues, that induce the ubiquitin-proteasome system or autophagy to selectively degrade specific disease-causing proteins.
Therapeutic application of light, typically in the red or near-infrared spectrum, to stimulate cellular function, reduce inflammation, and promote healing, often involving specific wavelengths and irradiance levels.
Engineering of artificial subwavelength structures (meta-atoms) to create metasurfaces that manipulate light properties (phase, polarization, wavelength) for multi-functional optical devices.
Techniques for driving electrophoretic displays, including managing remnant voltage, optimizing particle movement, and specific addressing pulse schemes to improve optical quality and update speed.
Patents
Showing 1-7 of 7
Metasurface & Diffractive Optics